Heart News and Research

RSS

Lifetime risks for total CVD are high regardless of index age

Even in men and women with an optimal cardiovascular disease (CVD) risk factor profile, the lifetime risk estimate for CVD is greater than 30 percent, and is more than 50 percent for men and women overall, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease.

6 Nov 2012

ICD use can combat sudden death in pediatric patients with hypertrophic cardiomyopathy

A multicenter registry has demonstrated that the use of implantable cardioverter-defibrillators (ICDs) to combat sudden cardiac death in high-risk pediatric patients suffering from hypertrophic cardiomyopathy (HCM). The study is being presented Nov. 5 at the 2012 Scientific Sessions of the American Heart Association (AHA) in Los Angeles.

6 Nov 2012

Keeping cardiovascular disease risk factors low may lead to a longer, healthier life

If you have optimal heart health in middle age, you may live up to 14 years longer, free of cardiovascular disease, than your peers who have two or more cardiovascular disease (CVD) risk factors, according to a new Northwestern Medicine study.

6 Nov 2012

Intravenous infusion of HDL cholesterol could reduce risk of subsequent heart attack

An intravenous infusion of good cholesterol could reduce the risk of a subsequent heart attack, researchers reported at the American Heart Association's Scientific Sessions 2012.

6 Nov 2012

Adenovirus detection not uncommon among children with Kawasaki disease

Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide Children's Hospital appearing in Clinical Infectious Diseases, adenovirus detection is not uncommon among children with Kawasaki disease.

5 Nov 2012

Study: Many Hispanic/Latino adults in the U.S. are at high risk for heart attack or stroke

A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.

5 Nov 2012

No link between daily multivitamin use and reduction of major cardiovascular events in men

In a randomized study that included nearly 15,000 male physicians who were middle-aged or older, daily multivitamin use for more than 10 years of treatment and follow-up did not result in a reduction of major cardiovascular events, heart attack, stroke, or death from cardiovascular disease, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease.

5 Nov 2012

Smoke-free laws lead to fewer heart attacks

A recent decline in the incidence of myocardial infarction in Olmsted County, Minnesota, USA, could be due to the implementation of smoke-free laws, researchers suggest.

5 Nov 2012

Study compares effectiveness of CABG surgery with PCI for adults with diabetes and heart disease

Adults with diabetes and multi-vessel coronary heart disease who underwent cardiac bypass surgery had better overall heart-related outcomes than those who underwent an artery-opening procedure to improve blood flow to the heart muscle, according to the results from an international study. The research was supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

5 Nov 2012

Family members less likely to administer CPR for cardiac arrests: Japanese study

Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.

5 Nov 2012

Pradaxa use does not appear to increase serious bleeding

The U.S. Food and Drug Administration (FDA) today announced the results of a Mini-Sentinel assessment that indicates bleeding rates associated with new use of Pradaxa (dabigatran etexilate mesylate) capsules do not appear to be higher than bleeding rates associated with new use of warfarin, which is consistent with observations from the pivotal RE-LY trial.

4 Nov 2012

New energy-harvesting device can power pacemakers

An experimental device converted energy from a beating heart to provide enough electricity to power a pacemaker, in a study presented at the American Heart Association's Scientific Sessions 2012.

4 Nov 2012

Mass. adopts stricter rules, penalties for compounding pharmacies

The emergency regulations will allow the state to monitor contamination and the volume of medicines being made.

3 Nov 2012

New studies support limiting daily sodium consumption to less than 1,500mg

New studies support limiting daily sodium consumption to less than 1,500 milligrams, according to a new American Heart Association presidential advisory.

3 Nov 2012

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

Amgen will present data from four Phase 2 trials of AMG 145, an investigational fully human monoclonal antibody directed against PCSK9, a protein that reduces the liver's ability to remove low density lipoprotein cholesterol, or "bad" cholesterol from the blood, at the upcoming American Heart Association Scientific Sessions 2012.

3 Nov 2012

Pfizer, Bristol-Myers Squibb announce data from ELIQUIS clinical trial on AF

Bristol-Myers Squibb Company and Pfizer Inc. today announced that a large number of data presentations sponsored by the companies on ELIQUIS (apixaban) and the treatment of atrial fibrillation will be presented at the American Heart Association 2012 Scientific Sessions, November 3-7, 2012, in Los Angeles, California.

3 Nov 2012

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder.

3 Nov 2012

Heart News and Research

Lifetime risks for total CVD are high regardless of index age

ICD use can combat sudden death in pediatric patients with hypertrophic cardiomyopathy

Keeping cardiovascular disease risk factors low may lead to a longer, healthier life

Intravenous infusion of HDL cholesterol could reduce risk of subsequent heart attack

Adenovirus detection not uncommon among children with Kawasaki disease

Study: Many Hispanic/Latino adults in the U.S. are at high risk for heart attack or stroke

No link between daily multivitamin use and reduction of major cardiovascular events in men

Smoke-free laws lead to fewer heart attacks

Study compares effectiveness of CABG surgery with PCI for adults with diabetes and heart disease

Family members less likely to administer CPR for cardiac arrests: Japanese study

Pradaxa use does not appear to increase serious bleeding

New energy-harvesting device can power pacemakers

Mass. adopts stricter rules, penalties for compounding pharmacies

New studies support limiting daily sodium consumption to less than 1,500mg

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

Pfizer, Bristol-Myers Squibb announce data from ELIQUIS clinical trial on AF

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

Health Net provides public with information on how to help prevent diabetes

NY-Presbyterian/CUMC wins two Transplant Program Awards from HSS

FDA expands Janssen’s Xarelto use to reduce risk of DVT and PE

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News